Drug intelligence / Profile preview

Wei Yan Granule

Development stage: Preclinical
Lead developer: Ministry of Science and Technology of the People’s Republic of China
Administration: Oral

Overview

Wei Yan Granule is a Traditional Chinese Medicine (TCM) formulation developed for the treatment of chronic superficial gastritis. It is being investigated in different formulations, specifically "No. I Wei Yan Granuo" for participants categorized with the "Gan Wei Bu He" TCM pattern and "No. II Wei Yan Granuo" for those with the "Pi Wei Shi Re" TCM pattern, reflecting a tailored approach based on traditional Chinese diagnostic principles.

Other names: No. I Wei Yan GranuoNo. II Wei Yan Granuo

Beyond the preview

Go deeper on Wei Yan Granule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wei Yan Granule.

Explore the full profile